In June 2011 the FDA issued a warning on the cholesterol lowering medication simvastatin. Also known by the brand name Zocor, the FDA cited fears that the 80mg dosage form of the drug caused severe muscle inflammation called myopathy in its users.
Now a study from the University of Washington supports the FDA concerns ...
[Read the rest of this article...]